Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06452797 · ClinicalTrials.gov registry record · NA

Prognostic Estimates Among ICU Clinicians

A NA study of Mechanical Ventilation, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
238
Enrollment target
3
Study locations

NCT06452797: Recruiting NA study of Mechanical Ventilation, sponsored by Rush University Medical Center.

NCT06452797 is a NA study of Mechanical Ventilation that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 238 participants, below the 580-participant average among 14 other Mechanical Ventilation trials with a reported enrollment target (59% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06452797, a NA study of Mechanical Ventilation, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
238 participants
Enrollment target
3
Study locations

Study Summary

One challenge with decision making for mechanically ventilated is that their prognosis is often uncertain. The ProVent-14 score incorporates clinical variables measured on the 14th day of mechanical ventilation to predict risk of death in one year. The ProVent-14 is easy to calculate has been externally validated. However, it is unclear how often clinicians use the ProVent-14 score to predict long-term outcomes for patients requiring 14 days of mechanical ventilation or if it helps clinicians make more accurate predictions. The purpose of this study is to determine whether ICU clinicians who receive a patient's ProVent-14 score make more accurate predictions for mortality at one year than ICU clinicians who do not.

Primary Outcome

Associations between participant predictions (0-100% risk of death) and patient outcomes (death or not) will be determined using logistic regression. Accuracy will be determined by Area Under the Receiver Operating Characteristic (AUROC) analysis.

Conditions Studied

Interventions

  • BEHAVIORAL ProVent-14 score

Study Locations (3)

Illinois

  • Rush University Medical Center - Chicago
  • Rush Oak Park Hospital - Oak Park

North Carolina

  • University of North Carolina - Chapel Hill

Trial Details

FieldValue
Enrollment Target 238 participants
Start Date 2024-06-18
Est. Completion 2027-06-15
Phase NA
Rush University Medical Center

320 total trials

What NCT06452797 shows while recruiting

NCT06452797 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 580-participant average among 14 other Mechanical Ventilation trials with a reported enrollment target (59% lower).

The record links to 1 condition, with Mechanical Ventilation appearing as the primary indexed condition, and to 1 intervention - of which ProVent-14 score is the first listed.

NCT06452797 reports a single indexed study location in Illinois, North Carolina.

Frequently Asked Questions

What is clinical trial NCT06452797 about?

NCT06452797 is a clinical study titled "Prognostic Estimates Among ICU Clinicians". One challenge with decision making for mechanically ventilated is that their prognosis is often uncertain. The ProVent-14 score incorporates clinical variables measured on the 14th day of mechanical ventilation to predict risk of death in one year. The ProVent-14 is easy to calculate has been extern...

What is the current status of trial NCT06452797?

This trial is currently recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2024-06-18. Estimated completion is 2027-06-15.

What conditions does trial NCT06452797 study?

This clinical trial studies the following conditions: Mechanical Ventilation.

What interventions are being tested in trial NCT06452797?

The interventions under investigation include: ProVent-14 score (BEHAVIORAL).

Who is sponsoring clinical trial NCT06452797?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06452797 being conducted?

This trial has 3 study locations across Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mechanical Ventilation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06452797's enrollment target sits among peer trials

238 10th of 14 higher than 5 of 14 other Mechanical Ventilation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mechanical Ventilation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05012072 · 238 participants · NA

    Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

  • NCT05400252 · 238 participants · NA

    Whole Health in VA Mental Health: Omnis Salutis

  • NCT06380517 · 238 participants · Phase 3

    Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

  • NCT06460012 · 238 participants · NA

    Support Via Technology: Living and Learning With Advancing Dementia-REVISED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06452797, the US trial registry maintained by the National Library of Medicine. NCT06452797 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.